Stay updated on PCSK9 Inhibition Effect on CV Risk in Treated HIV Clinical Trial
Sign up to get notified when there's something new on the PCSK9 Inhibition Effect on CV Risk in Treated HIV Clinical Trial page.

Latest updates to the PCSK9 Inhibition Effect on CV Risk in Treated HIV Clinical Trial page
- Check2 days agoChange DetectedA new revision entry 'Revision: v3.6.5' was added to the study record history, and the previous 'Revision: v3.6.4' entry was removed.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedA new revision entry v3.6.4 was added to the record history. The previous revision v3.6.3 was removed, updating the page's version history.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check38 days agoChange DetectedA new revision entry v3.6.3 was added to the study's history, and the previous revision v3.6.2 was removed from the current revision list.SummaryDifference0.1%

- Check45 days agoChange DetectedThe page history now shows a newer site revision label (v3.6.2) replacing the previous revision (v3.6.0), indicating a minor internal update to the page.SummaryDifference0.1%

- Check59 days agoChange DetectedThe history now shows the study is no longer recruiting participants, with a new revision tag (v3.6.0) added and the previous tag (v3.5.5) removed.SummaryDifference0.4%

- Check66 days agoChange DetectedA new revision entry v3.5.5 appears in the page's revision history. The previous entry v3.5.4 is removed from the history list.SummaryDifference0.1%

Stay in the know with updates to PCSK9 Inhibition Effect on CV Risk in Treated HIV Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PCSK9 Inhibition Effect on CV Risk in Treated HIV Clinical Trial page.